Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Mindbio Therapeutics Corp. ( (TSE:MBIO) ) has issued an announcement.
MindBio Therapeutics Corp. has successfully raised $1.1 million through a non-brokered private placement, issuing AI and LIFE units to accredited investors and under the listed issuer financing exemption. The funds will be used to advance the company’s prediction technologies for drug and alcohol intoxication detection and for general working capital. This strategic move is expected to enhance MindBio’s capabilities in consumer and enterprise applications, potentially strengthening its market position in the biotechnology sector.
More about Mindbio Therapeutics Corp.
MindBio Therapeutics Corp. is a clinical-stage biotechnology company based in Vancouver, British Columbia. The company focuses on developing novel treatments for mental health disorders and health prediction technologies using AI and machine learning.
Average Trading Volume: 2,636
Technical Sentiment Signal: Sell
Current Market Cap: C$6.64M
For detailed information about MBIO stock, go to TipRanks’ Stock Analysis page.